2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers))
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers)) Product Information
2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers)) is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-100445.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers))
CAS No.
1373318-85-4
CAT No.
CS-T-100445
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C27H38D9N5O5
Molecular Weight
530.75
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers)) is supplied with detailed characterization data compliant with regulatory guideline. 2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers)) can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
A labelled metabolite of the Hepatitis C virus NS3 serine protease inhibitor Boceprevir (B675500). It is a COVID19-related research product.
Synonyms
2’-Dihydro Boceprevir-d9(Boceprevir Metabolite M28-d9+M31-d9 (Mixture of Diastereomers))
Application Notes
A labelled metabolite of the Hepatitis C virus NS3 serine protease inhibitor Boceprevir (B675500). It is a COVID19-related research product.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.